These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 2620357)
21. [Bioethical considerations of genetic engineering]. González-Fraguela ME Rev Neurol; 2002 Oct 16-31; 35(8):701-4. PubMed ID: 12402218 [TBL] [Abstract][Full Text] [Related]
22. The use of picornaviruses as vectors for the engineering of live recombinant vaccines. Girard M; Altmeyer R; van der Werf S; Wychowski C; Martin A Biologicals; 1995 Jun; 23(2):165-9. PubMed ID: 7546659 [No Abstract] [Full Text] [Related]
23. Recombinant DNA manipulations and their interfaces with protein technology. Nagley P Dev Biol Stand; 1987; 67():171-6. PubMed ID: 3475224 [TBL] [Abstract][Full Text] [Related]
24. Applications of insect cell gene expression in pharmaceutical research. Thomsen DR; Meyer AL; Post LE Bioprocess Technol; 1993; 17():105-38. PubMed ID: 7764046 [No Abstract] [Full Text] [Related]
25. Control of therapeutic goods produced by recombinant DNA technology. Breschkin A Dev Biol Stand; 1987; 67():207-11. PubMed ID: 3475226 [TBL] [Abstract][Full Text] [Related]
26. Antibody engineering for the development of therapeutic antibodies. Kim SJ; Park Y; Hong HJ Mol Cells; 2005 Aug; 20(1):17-29. PubMed ID: 16258237 [TBL] [Abstract][Full Text] [Related]
27. [Prospects and achievements of genetic engineering in development of antiviral vaccines]. Tikhonenko TI Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971 [TBL] [Abstract][Full Text] [Related]
29. Antibody engineering: facing new challenges in cancer therapy. Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728 [TBL] [Abstract][Full Text] [Related]
30. Expression and delivery of heterologous antigens using lactic acid bacteria. Reuter MA; Hanniffy S; Wells JM Methods Mol Med; 2003; 87():101-14. PubMed ID: 12958452 [No Abstract] [Full Text] [Related]
31. Monoclonal and recombinant antibodies, 30 years after .. Laffly E; Sodoyer R Hum Antibodies; 2005; 14(1-2):33-55. PubMed ID: 16424599 [TBL] [Abstract][Full Text] [Related]
37. Production of target-specific recombinant human polyclonal antibodies in mammalian cells. Wiberg FC; Rasmussen SK; Frandsen TP; Rasmussen LK; Tengbjerg K; Coljee VW; Sharon J; Yang CY; Bregenholt S; Nielsen LS; Haurum JS; Tolstrup AB Biotechnol Bioeng; 2006 Jun; 94(2):396-405. PubMed ID: 16596663 [TBL] [Abstract][Full Text] [Related]
38. Magnifection--a new platform for expressing recombinant vaccines in plants. Gleba Y; Klimyuk V; Marillonnet S Vaccine; 2005 Mar; 23(17-18):2042-8. PubMed ID: 15755568 [TBL] [Abstract][Full Text] [Related]
39. [Gene technology in clinical medicine--technics and tools]. Børresen AL Tidsskr Nor Laegeforen; 1989 Oct; 109(28):2882-7. PubMed ID: 2815027 [TBL] [Abstract][Full Text] [Related]
40. [New horizons for medicine on the basis of genetic technology]. Werner RG Arzneimittelforschung; 1995 Sep; 45(9):1040-7. PubMed ID: 7488308 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]